In vitro Antiviral Activity of Kabasura Kudineer - Siddha Polyherbal Formulation Against Novel Coronavirus (SARS-CoV-2) (preprint)

Kabasura Kudineer (KSK) is a Sastric Siddha polyherbal formulation that has been used to treat the fever with influenza-like indication. The purpose of this study is to validate the antiviral activity of KSK against the novel SARS-CoV-2 virus. The antiviral activity of KSK against SARS-CoV-2 was assessed in Vero E6 cells and followed by an RT-PCR assay. KSK significantly inhibited SARS-CoV-2 replication in Vero E6 cells. These data indicate that KSK prevents the attack of its virus, rendering the use of these a novel COVID-19 infectious diseases strategy.